GT201700041A - ANAMORELINE BASED MEDICAL TREATMENTS - Google Patents

ANAMORELINE BASED MEDICAL TREATMENTS

Info

Publication number
GT201700041A
GT201700041A GT201700041A GT201700041A GT201700041A GT 201700041 A GT201700041 A GT 201700041A GT 201700041 A GT201700041 A GT 201700041A GT 201700041 A GT201700041 A GT 201700041A GT 201700041 A GT201700041 A GT 201700041A
Authority
GT
Guatemala
Prior art keywords
anamoreline
medical treatments
based medical
cancer
treatment
Prior art date
Application number
GT201700041A
Other languages
Spanish (es)
Inventor
Mann William
Friend John
Polvino William
Allen Suzan
Lu Ming
Duus Elizabeth
Giorgino Ruben
Baroni Enrico
Original Assignee
Helsinn Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helsinn Healthcare Sa filed Critical Helsinn Healthcare Sa
Publication of GT201700041A publication Critical patent/GT201700041A/en

Links

Abstract

SE DESCRIBEN MÉTODOS DE TRATAMIENTO DE AFECCIONES RELACIONADAS CON EL CÁNCER USANDO ANAMORELINA. LA MODALIDAD PRINCIPAL SE RELACIONA CON LA AFECCIÓN ÚNICA DE PACIENTES QUE LA DEFINEN MEDIANTE EL TRATAMIENTO DE LA CAQUEXIA EN UN PACIENTE HUMANO CON CÁNCER, QUE COMPRENDE LA ADMINISTRACIÓN A DICHO PACIENTE DE UNA CANTIDAD TERAPÉUTICAMENTE EFECTIVA DE ANAMORELINA DURANTE UN PERÍODO TERAPÉUTICAMENTE EFECTIVO, Y LA SORPRENDENTE CAPACIDAD OBSERVADA DE LA ANAMORELINA DE AUMENTAR LA MASA CORPORAL MAGRA DE ESTA POBLACIÓN.METHODS OF TREATMENT OF AFFECTIONS RELATED TO CANCER USING ANAMORELINE ARE DESCRIBED. THE MAIN MODALITY IS RELATED TO THE SINGLE AFFECTION OF PATIENTS DEFINING THEM BY MEANS OF THE TREATMENT OF CAQUEXY IN A HUMAN PATIENT WITH CANCER, WHICH UNDERSTANDS THE PATIENT ADMINISTRATION OF A THERAPEUTICALLY EFFECTIVE AMOUNT OF THE NON-PERFORMALLY PERFORMANTLY NORMAL PERFORMANCE. OBSERVED CAPACITY OF ANAMORELINE TO INCREASE THE MAGRA BODY MASS OF THIS POPULATION.

GT201700041A 2014-09-04 2017-03-02 ANAMORELINE BASED MEDICAL TREATMENTS GT201700041A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462945976P 2014-09-04 2014-09-04

Publications (1)

Publication Number Publication Date
GT201700041A true GT201700041A (en) 2019-05-22

Family

ID=66911988

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201700041A GT201700041A (en) 2014-09-04 2017-03-02 ANAMORELINE BASED MEDICAL TREATMENTS

Country Status (1)

Country Link
GT (1) GT201700041A (en)

Similar Documents

Publication Publication Date Title
CL2017000494A1 (en) Medical treatments based on anamorelin.
TWD196868S (en) Ultrasound therapeutic treatment handpiece
MY174727A (en) Stable, protracted glp-1/glucagon receptor co-agonists for medical use
CL2018001677A1 (en) Treatment of fabry disease in patients not treated and previously treated with ert
PH12014501997A1 (en) Esketamine for the treatment of treatment-refractory or treatment-resistant depression
EA201991484A1 (en) MEDICINAL FORMS OF ENZALUTAMIDE
EP3141603A4 (en) Gpc3-targeted therapeutic agent for administration to patients for whom gpc3-targeted therapeutic agent therapy is effective
BR112017023170A2 (en) medicinal bath device and its use
CO6592015A2 (en) Methods and compositions to reduce or prevent vascular cladification during peritoneal dialysis treatment
EA201501164A1 (en) SOLID PHARMACEUTICAL MEDICINE FORM
EA201071209A1 (en) APPLICATION OF DRUNEDARON OR ITS PHARMACEUTICALLY ACCEPTABLE SALT FOR OBTAINING A MEDICINE TO REGULATE KALIUM IN THE BLOOD
GB2554591A (en) Clinical support system and method
GT201700041A (en) ANAMORELINE BASED MEDICAL TREATMENTS
BR112018068910A2 (en) sultiame for the treatment of sleep apnea
EA201991866A1 (en) COMBINED THERAPY
NZ740627A (en) Oral suspension for treating eosinophilic esophagitis
EA201692163A1 (en) MEDICINE FOR THE TREATMENT OF PATIENTS WITH TINNITUS
PL417551A1 (en) Application of insulin for treatment of a diabetic foot in the form of direct injection into the bad foot
UA112033U (en) METHOD OF TREATMENT OF COMPLIED VARIQUE DISEASE OF LOWER LIMBS
AR081669A1 (en) SEMULOPARINE FOR USE AS AN ANTHROMBROTIC TREATMENT IN ORTHOPEDIC SURGERY WITH IMPROVED PROFIT-RISK PROFILE
CN105476179A (en) Medication healthcare insole
PL414619A1 (en) Medical application of the extract from Centaurea borysthenica Gruner herb in cardioprotective therapy
RU2012135942A (en) METHOD FOR TREATING PATIENTS WITH GALLSTONE DISEASE OF THE FIRST STAGE
TH158984A (en) Therapeutic active compounds and their methods of use
RU2013139670A (en) APPLICATION OF THE COMBINATION OF ANGIOTENZINE-TURNING ENZYME INHIBITOR AND EPIPHYSIS HORMONE FOR TREATMENT OF ISCHEMIC HEART DISEASE IN ELDERLY PATIENTS